Untypical secondary cancer after radiotherapy for prostate cancer

Czech version

Authors: Petr Tureček; Martin Sutorý
Authors‘ workplace: Urologie, Úrazová nemocnice Brno
Published in: Ces Urol 2017; 21(4): 314-318
Category: Case report

Overview

On two case studies from our department we present emergence of untypical secondary malignant disease at patients with a primary adenocarcinoma of prostate having been treated by conventional curative radiotherapy. We want to point out a general risk of secondary malignity, which can be omitted in practice, and certain diagnostic pitfalls as well.

Key words:
Secondary cancer, prostate cancer, radiotherapy, spinocellular cancer, malignant melanoma.

Sources

1. Bostrom PJ, Soloway MS. Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk? European Urology 2007; 52: 973–982.

2. Geryk E, Dítě P, Kozel J, Štampach R, Kubíček P, Odehnal J. Další primární novotvary u nemocných s karcinomem prostaty ve srovnání s jeho incidencí, mortalitou a prevalencí. Onkologie 2010; 4(2): 89–93.

3. Klementová Y. Radioterapie karcinomu prostaty – nežádoucí účinky léčby. Urolog. praxi 2011; 12(1): 59–60.

4. Brenner DJ, Curtis RE, Hall EJ, Ron E. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 2000; 1/88(2): 398–406.

5. Čoupková I, Čoupek P, Krupa P, Šlampa P. Komplikace spojené s radioterapií karcinomu prostaty, jejich prevence a léčba. Urolog. praxi 2011; 12(5): 292–294.

6. Murray L, Henry A, Hoskin P, Siebert FA, Venselaar J. On behalf of the PROBATE group of the GEC ESTRO. Radiotherapy and Oncology 2014; 110: 213–228.

7. Sountoulides P, Koletsas N, Kikidakis D, Paschalidis K, Sofikitis N. Secondary malignancies following radiotherapy for prostate cancer. Ther Adv Urol. 2010; 2(3): 119–125.

8. Wallis ChJD, Mahar AL, Choo R, et al. Second malignancies after radiotherapy for prostate cancer: systematic review and meta‑analysis. BMJ 2016; 352: i851.